1
|
Damour A, Delalande P, Cordelières F, Lafon ME, Faure M, Segovia-Kueny S, Stalens C, Mathis S, Spinazzi M, Violleau MH, Wodrich H, Solé G. Anti-SARS-CoV-2 (COVID-19) vaccination efficacy in patients with severe neuromuscular diseases. Rev Neurol (Paris) 2023; 179:983-992. [PMID: 37633734 DOI: 10.1016/j.neurol.2023.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Revised: 03/23/2023] [Accepted: 04/11/2023] [Indexed: 08/28/2023]
Abstract
INTRODUCTION Patients with severe neuromuscular disease (sNMD) are considered at high risk of severe COVID-19. Muscle tissue is often replaced by fibroadipose tissue in these diseases whereas the new mRNA-based vaccines are injected intramuscularly. We aimed at evaluating the efficacy of two injections associated with a booster injection of mRNA vaccine in these patients. METHODS We performed an observational, prospective, single-centre study to investigate the level of anti-S antibodies (Abs) and their neutralization activity at weeks 6 (W6) and 24 (W24) after two injections of mRNA-1273 vaccine and at weeks 12 (BW12) and 29 (BW29) after a booster injection of BNT162b2 vaccine in patients with sNMD. RESULTS Thirty-three patients with sNMD were included. At W6, 30 patients (90.1%) showed a protective serum level of specific anti-S Abs with a strong neutralization capacity. We observed a decline over time: only 12 patients (36.3%) retained anti-S Abs levels considered as protective at W24. The neutralization activity remained above the cut off in 23 (69.7%). The booster vaccination restored robust neutralization activity for all analysed 22 patients (100%) at BW12, which was maintained without any significant drop at BW29 (16). No severe adverse event was reported in this cohort and none of the 33 patients developed symptomatic COVID-19 over one year. CONCLUSIONS This study provides evidence that most sNMD patients receiving two injections of COVID-19 mRNA-based vaccines develop a strong humoral response after vaccination. A decline over time was observed but a single booster injection restores a long-term immunity. Moreover, no safety issues were observed.
Collapse
Affiliation(s)
- A Damour
- CNRS UMR 5234, Fundamental Microbiology and Pathogenicity, University Bordeaux, Bordeaux, France
| | - P Delalande
- MAS Yolaine-de-Kepper, Saint-Georges-sur-Loire, France
| | - F Cordelières
- Bordeaux Imaging Center, BIC, UMS 3420, US 4, University Bordeaux, CNRS, Inserm, Bordeaux, France
| | - M E Lafon
- CNRS UMR 5234, Fundamental Microbiology and Pathogenicity, University Bordeaux, Bordeaux, France; Virology Laboratory, Pellegrin Hospital, Bordeaux University Hospitals, Bordeaux, France
| | - M Faure
- CNRS UMR 5234, Fundamental Microbiology and Pathogenicity, University Bordeaux, Bordeaux, France
| | | | | | - S Mathis
- Neuromuscular Reference Center AOC, Neurology and Neuromuscular Diseases Department, Pellegrin Hospital, Bordeaux University Hospitals, Bordeaux, France
| | - M Spinazzi
- Neuromuscular Reference Center AOC, Neurology Department, Angers University Hospital Center, Angers, France
| | - M H Violleau
- Neuromuscular Reference Center AOC, Neurology and Neuromuscular Diseases Department, Pellegrin Hospital, Bordeaux University Hospitals, Bordeaux, France
| | - H Wodrich
- CNRS UMR 5234, Fundamental Microbiology and Pathogenicity, University Bordeaux, Bordeaux, France
| | - G Solé
- Neuromuscular Reference Center AOC, Neurology and Neuromuscular Diseases Department, Pellegrin Hospital, Bordeaux University Hospitals, Bordeaux, France.
| |
Collapse
|
2
|
Djaïleb L, De Leiris N, Canu M, Sy OP, Seiller A, Leenhardt J, Charlon C, Faure M, Caillard J, Broisat A, Borel AL, Lablanche S, Betry C, Ghezzi C, Vanzetto G, Fagret D, Riou LM, Barone-Rochette G. Regional CZT myocardial perfusion reserve for the detection of territories with simultaneously impaired CFR and IMR in patients without obstructive coronary artery disease: a pilot study. J Nucl Cardiol 2023; 30:1656-1667. [PMID: 36813934 DOI: 10.1007/s12350-023-03206-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Accepted: 01/06/2023] [Indexed: 02/24/2023]
Abstract
OBJECTIVES To assess the diagnostic performances of CZT myocardial perfusion reserve (MPR) for the detection of territories with simultaneous impaired coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) in patients without obstructive coronary artery disease. METHODS Patients were prospectively included before being referred for coronary angiography. All patients underwent CZT MPR before invasive coronary angiography (ICA) and coronary physiology assessment. Rest and dipyridamole-induced stress myocardial blood flow (MBF) and MPR were quantified using 99mTc-SestaMIBI and a CZT camera. Fractional flow reserve (FFR), Thermodilution CFR, and IMR were assessed during ICA. RESULTS Between December 2016 and July 2019, 36 patients were included. 25/36 patients presented no obstructive coronary artery disease. A complete functional assessment was performed in 32 arteries. No territory presented a significant ischemia on CZT myocardial perfusion imaging. A moderate yet significant correlation was observed between regional CZT MPR and CFR (r = 0.4, P = .03). Sensitivity, specificity, positive and negative predictive value, and accuracy of regional CZT MPR versus the composite invasive criterion (impaired CFR and IMR) were 87 [47% to 99%], 92% [73% to 99%], 78% [47% to 93%], 96% [78% to 99%], and 91% [75% to 98%], respectively. All territories with a regional CZT MPR ≤ 1.8 showed a CFR < 2. Regional CZT MPR values were significantly higher in arteries with CFR ≥ 2 and IMR < 25 (negative composite criterion, n = 14) than in those with CFR < 2 and IMR ≥ 25 (2.6 [2.1 to 3.6] versus 1.6 [1.2 to 1.8]), P < .01). CONCLUSION Regional CZT MPR presented excellent diagnostic performances for the detection of territories with simultaneously impaired CFR and IMR reflecting a very high cardiovascular risk in patients without obstructive coronary artery disease.
Collapse
Affiliation(s)
- Loïc Djaïleb
- Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France.
| | - Nicolas De Leiris
- Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Marjorie Canu
- Cardiology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Olivier Phan Sy
- Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Alexandre Seiller
- Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Julien Leenhardt
- Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Clémence Charlon
- Cardiology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Marine Faure
- Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Jessica Caillard
- Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Alexis Broisat
- INSERM, LRB, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Anne-Laure Borel
- Endocrinology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Sandrine Lablanche
- Endocrinology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Cécile Betry
- Endocrinology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | | | - Gérald Vanzetto
- Cardiology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Daniel Fagret
- Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Laurent M Riou
- INSERM, LRB, Univ. Grenoble Alpes, 38000, Grenoble, France
| | - Gilles Barone-Rochette
- Cardiology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France
| |
Collapse
|
3
|
Vanholder R, Bé A, Scheres E, Faure M. Policy forum in the European Parliament: calling for a paradigm shift towards green kidney care. J Nephrol 2023; 36:1225-1227. [PMID: 37310612 DOI: 10.1007/s40620-023-01692-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- Raymond Vanholder
- Nephrology Section, Department of Internal Medicine and Pediatrics, University Hospital, Corneel Heymanslaan, 10, 9000, Ghent, Belgium.
- European Kidney Health Alliance, Brussels, Belgium.
| | - Alicia Bé
- European Kidney Health Alliance, Brussels, Belgium
- Dentons Global Advisors, Health Practice, Brussels, Belgium
| | - Eveline Scheres
- European Kidney Health Alliance, Brussels, Belgium
- Buitendelijnen, Utrecht, The Netherlands
| | - Marine Faure
- European Kidney Health Alliance, Brussels, Belgium
- Dentons Global Advisors, Health Practice, Brussels, Belgium
| |
Collapse
|
4
|
Herion FX, Beurton A, Oddos C, Nubret K, Aguerreche C, Faure M, Gerbaud E, Pernot M, Imbault J, Ouattara A. Multidisciplinary shock team approach improves long-term outcomes of patients suffering from cardiogenic shock treated by short term mechanical circulatory support (STMCS). Archives of Cardiovascular Diseases Supplements 2023. [DOI: 10.1016/j.acvdsp.2022.10.312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
5
|
Barré T, Carrat F, Ramier C, Fontaine H, Di Beo V, Bureau M, Dorival C, Larrey D, Delarocque-Astagneau E, Mathurin P, Marcellin F, Petrov-Sanchez V, Cagnot C, Carrieri P, Pol S, Protopopescu C, Alric L, Pomes C, Zoulim F, Maynard M, Bai R, Hucault L, Bailly F, Raffi F, Billaud E, Boutoille D, Lefebvre M, André-Garnier E, Cales P, Hubert I, Lannes A, Lunel F, Boursier J, Asselah T, Boyer N, Giuily N, Castelnau C, Scoazec G, Pol S, Fontaine H, Rousseaud E, Vallet-Pichard A, Sogni P, de Ledinghen V, Foucher J, Hiriart JB, M’Bouyou J, Irlès-Depé M, Bourlière M, Ahmed SNS, Oules V, Tran A, Anty R, Gelsi E, Truchi R, Thabut D, Hammeche S, Moussali J, Causse X, De Dieuleveult B, Ouarani B, Labarrière D, Ganne N, Grando-Lemaire V, Nahon P, Brulé S, Ulker B, Guyader D, Jezequel C, Brener A, Laligant A, Rabot A, Renard I, Habersetzer F, Baumert TF, Doffoel M, Mutter C, Simo-Noumbissie P, Razi E, Bronowicki JP, Barraud H, Bensenane M, Nani A, Hassani-Nani S, Bernard MA, Pageaux GP, Larrey D, Meszaros M, Metivier S, Bureau C, Morales T, Peron JM, Robic MA, Decaens T, Faure M, Froissart B, Hilleret MN, Zarski JP, Riachi G, Goria O, Paris F, Montialoux H, Leroy V, Amaddeo G, Varaut A, Simoes M, Amzal R, Chazouillières O, Andreani T, Angoulevant B, Chevance A, Serfaty L, Samuel D, Antonini T, Coilly A, Duclos-Vallée JC, Tateo M, Abergel A, Reymond M, Brigitte C, Benjamin B, Muti L, Geist C, Conroy G, Riffault R, Rosa I, Barrault C, Costes L, Hagège H, Loustaud-Ratti V, Carrier P, Debette-Gratien M, Mathurin P, Lassailly G, Lemaitre E, Canva V, Dharancy S, Louvet A, Minello A, Latournerie M, Bardou M, Mouillot T, D’Alteroche L, Barbereau D, Nicolas C, Elkrief L, Jaillais A, Gournay J, Chevalier C, Archambeaud I, Habes S, Portal I, Gelu-Simeon M, Saillard E, Lafrance MJ, Catherine L, Carrat F, Chau F, Dorival C, Goderel I, Lusivika-Nzinga C, Bellance MA, Bellet J, Monfalet P, Chane-Teng J, Bijaoui S, Pannetier G, Téoulé F, Nicol J, Sebal F, Bekhti R, Cagnot C, Boston A, Nailler L, Le Meut G, Diallo A, Petrov-Sanchez V, Bourlière M, Boursier J, Carrat F, Carrieri P, Delarocque-Astagneau E, De Ledinghen V, Dorival C, Fontaine H, Fourati S, Housset C, Larrey D, Nahon P, Pageaux GP, Petrov-Sanchez V, Pol S, Bruyand M, Wittkop L, Zoulim F, Zucman-Rossi J, L’hennaff M, Sizorn M, Cagnot C. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort. J Cannabis Res 2022; 4:31. [PMID: 35690798 PMCID: PMC9188079 DOI: 10.1186/s42238-022-00138-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Accepted: 05/19/2022] [Indexed: 11/21/2022] Open
Abstract
Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated with lower corpulence in various populations. However, this relationship has not yet been studied in persons with chronic HCV infection. Methods Using baseline data from the French ANRS CO22 Hepather cohort, we used binary logistic and multinomial logistic regression models to test for an inverse relationship between cannabis use (former/current) and (i) central obesity (i.e., large waist circumference) and (ii) overweight and obesity (i.e., elevated body mass index (BMI)) in patients from the cohort who had chronic HCV infection. We also tested for relationships between cannabis use and both waist circumference and BMI as continuous variables, using linear regression models. Results Among the 6348 participants in the study population, 55% had central obesity, 13.7% had obesity according to their BMI, and 12.4% were current cannabis users. After multivariable adjustment, current cannabis use was associated with lower risk of central obesity (adjusted odds ratio, aOR [95% confidence interval, CI]: 0.45 [0.37–0.55]), BMI-based obesity (adjusted relative risk ratio (aRRR) [95% CI]: 0.27 [0.19–0.39]), and overweight (aRRR [95% CI]: 0.47 [0.38–0.59]). This was also true for former use, but to a lesser extent. Former and current cannabis use were inversely associated with waist circumference and BMI. Conclusions We found that former and, to a greater extent, current cannabis use were consistently associated with smaller waist circumference, lower BMI, and lower risks of overweight, obesity, and central obesity in patients with chronic HCV infection. Longitudinal studies are needed to confirm these relationships and to assess the effect of cannabis use on corpulence and liver outcomes after HCV cure. Trial registration ClinicalTrials.gov identifier: NCT01953458.
Collapse
|
6
|
Durand D, Faure M, Lamberton P, Lemosquet S, de Boyer des Roches A. A multiparametric approach to assessing residual pain experienced by dairy cows undergoing digestive tract surgery under multimodal analgesia. Animal 2021; 15:100338. [PMID: 34418866 DOI: 10.1016/j.animal.2021.100338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Revised: 07/15/2021] [Accepted: 07/16/2021] [Indexed: 11/17/2022] Open
Abstract
This study assessed residual pain responses of dairy cows undergoing fistulation surgery under multimodal analgesia using a multiparametric method combining behavioural and physiological indicators. A longitudinal study was conducted on five dairy cows, each acting as her own control. The surgery consisted of implanting a ruminal and a duodenal cannula in each cow. The multimodal drug protocol consisted of a combination of N-Methyl-D aspartic Acid antagonists, α2-agonists, and local anaesthetic during surgery, and non-steroidal anti-inflammatory drugs (NSAIDs) and opioid treatment postsurgery. Cow responses to surgery were monitored by direct behavioural observation, physiological assay indicators, and milk production from day (D) -6 days before surgery (D-6) to D13 postsurgery. From the data recorded, the variables that contributed most to the discrimination of days pre- and postsurgery were identified using factorial discriminant analysis. Components 1 and 2 of the factorial discriminant analysis explained 68.2% and 17.9%, respectively, of the total variance. Component 1 was mainly explained by haptoglobin (contribution to axis: 0.885), oxidative stress (ratio of oxidized gluthatione to reduced glutathione (GSH/GSSG), -0.746; vitamin E, -0.683; vitamin A, -0.597; malondialdehyde (MDA), 0.416), and behavioural indicators (general attitude, 0.594). On this axis, the higher the score, the higher were the apathy and haptoglobin and MDA concentrations, and the lower were the GSH/GSSG ratio and concentrations of vitamins A and E. This axis opposed cows on D-6 to cows on D3 and D5; cows on D1 and D13 were intermediate. Component 2 was mainly explained by the Hypothalamic-pituitary-adrenal axis (non-esterified fatty acid (NEFA), 0.686; cortisol, 0.669), milk yield (-0.725), oxidative stress (MDA, -0.584; nitric oxide (NO), 0.454), and behavioural indicators of pain (ear position, 0.467; leg postures, 0.431). On this axis, the higher the score, the higher the NEFA, cortisol, and nitric oxide concentrations; the more the ear and leg pain postures; and the lower the milk production and MDA concentrations. This axis opposed cows on D13 to cows on D1. These results suggest that cows may experience some pain only on D1, whereas on subsequent days, the inflammatory response and oxidative stress did not seem to be associated with pain. Our results should be considered for different surgeries to improve analgesia immediately after surgery, and to provide antioxidants along with NSAIDs to promote recovery.
Collapse
Affiliation(s)
- D Durand
- INRAE, Université Clermont Auvergne, VetAgro Sup, UMR Herbivores, 63122 Saint-Genès-Champanelle, France.
| | - M Faure
- INRAE, Université Clermont Auvergne, VetAgro Sup, UMR Herbivores, 63122 Saint-Genès-Champanelle, France
| | - P Lamberton
- PEGASE, INRAE, Institut Agro, 35590 Saint Gilles, France
| | - S Lemosquet
- PEGASE, INRAE, Institut Agro, 35590 Saint Gilles, France
| | - A de Boyer des Roches
- INRAE, Université Clermont Auvergne, VetAgro Sup, UMR Herbivores, 63122 Saint-Genès-Champanelle, France
| |
Collapse
|
7
|
Coustal C, Quantin X, Lesage C, Michot J, Laparra A, Ederhy S, Assenat E, Faure M, Issa N, Lambotte O, Puyade M, Dereure O, Rullier P, Serre I, Klouche K, Vernhet H, Faillie J, Roubille F, Guilpain P, Maria A. Facteurs pronostiques des myocardites induites par les inhibiteurs du checkpoint immunologique. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.03.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
8
|
Ruuth-Praz J, Faure M, Gomez E, Petit I, Petitpain N, Chaouat A, Chabot F. [Eosinophilic pneumonia: A rare complication of sodium divalproate]. Rev Mal Respir 2020; 37:590-594. [PMID: 32739035 DOI: 10.1016/j.rmr.2020.05.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2019] [Accepted: 05/24/2020] [Indexed: 10/23/2022]
Abstract
INTRODUCTION Eosinophilic pneumonias are characterized by an increase in lung eosinophils. These disorders can be induced by drug reactions. CASE REPORT A 57-year-old woman suffering from bipolar disorder and treated by sodium divalproate for more than 2 years was hospitalised in the department of respiratory medicine for dyspnoea and cough. The investigations showed severe hypoxaemia, airflow limitation, multiple ground-glass opacities and crazy paving on the chest CT-scan and a blood eosinophilia. A significant alveolar eosinophilia was found in the broncho-alveolar lavage. A complete assessment of possible causes was made. Finally, we made the diagnosis of eosinophilic pneumonia secondary to sodium divalproate. The treatment was stopped and systemic corticosteroid therapy was not introduced. The patient showed an improvement of her dyspnoea in a few days. Lung function and the CT-scan were normal within a few months. CONCLUSIONS Sodium divalproate, frequently used in the treatment of bipolar disorder, is a rare cause of eosinophilic lung disease, even years after its introduction. Rapid diagnosis and withdrawal of treatment led to complete resolution in the reported case.
Collapse
Affiliation(s)
- J Ruuth-Praz
- Département de pneumologie, CHRU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France.
| | - M Faure
- Service de pneumologie, médecine intensive et réanimation, Groupe hospitalier Pitié-Salpêtrière, Paris, France
| | - E Gomez
- Département de pneumologie, CHRU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - I Petit
- Département de radiologie, CHRU de Nancy, Vandœuvre-lès-Nancy, France
| | - N Petitpain
- Service de toxicologie et pharmacologie clinique, Centre régional de pharmacovigilance, CHRU de Nancy, Vandœuvre-lès-Nancy, France
| | - A Chaouat
- Département de pneumologie, CHRU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - F Chabot
- Département de pneumologie, CHRU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| |
Collapse
|
9
|
Golozar A, Faure M, Bergamasco A, Chen K, Arredondo-Bisonó T, Moride Y. EP1.12-19 Characteristics of Patients with Small-Cell Lung Cancer in the Real-World: A Systematic Review. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
10
|
Kahoul I, Knefati Y, Mondain J, Faure M, Bouklemoune M. Brèche péritonéo-péricardique chez une patiente en dialyse péritonéale. Nephrol Ther 2019. [DOI: 10.1016/j.nephro.2019.07.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
11
|
Garnier R, Thiault G, Gros-Daillon S, Faure M, Médernach C, Langrand J. Pollution par le benzène de l’air intérieur des logements situés au-dessus d’atelier de réparation de motocycles. Toxicologie Analytique et Clinique 2019. [DOI: 10.1016/j.toxac.2019.03.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
12
|
Faure M, Billon F, Le Potier I, Haghiri-Gosnet AM, Tribollet B, Pailleret A, Deslouis C, Gamby J. Improvement of electrochemical detection of transthyretin synthetic peptide and its amino acids on carbon electrodes: Glassy carbon versus amorphous carbon nitride a-CNx. Electrochim Acta 2019. [DOI: 10.1016/j.electacta.2018.11.022] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
13
|
Faure M, Minvielle C, Corré J. Among eligible patients after acute coronary syndrome, the prognosis of whom have performed cardiac rehabilitation is better than those who have not performed it. Archives of Cardiovascular Diseases Supplements 2019. [DOI: 10.1016/j.acvdsp.2018.10.247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
14
|
Faure M, Billon F, Haghiri-Gosnet AM, Tribollet B, Deslouis C, Pailleret A, Gamby J. Influence of the atomic nitrogen content in amorphous carbon nitride thin films on the modulation of their polarizable interfaces properties. Electrochim Acta 2018. [DOI: 10.1016/j.electacta.2018.05.116] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
15
|
Vermeulen S, Faure M, Luyckx E, Salgado R, Parizel P. Incidental CT finding of myocardial calcifications following severe septic shock. J Cardiovasc Comput Tomogr 2018; 12:e7-e8. [DOI: 10.1016/j.jcct.2017.09.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/14/2017] [Revised: 09/08/2017] [Accepted: 09/20/2017] [Indexed: 10/18/2022]
|
16
|
Fu D, Gratziou C, Jiménez-Ruiz C, Faure M, Ward B, Ravara S, Prasad VM, Mauer-Stender K, Kaur J, Ciobanu A, Huq SM, Katsaounou P. The WHO-ERS Smoking Cessation Training Project: the first year of experience. ERJ Open Res 2018; 4:00070-2018. [PMID: 30083549 PMCID: PMC6066529 DOI: 10.1183/23120541.00070-2018] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2018] [Accepted: 05/27/2018] [Indexed: 01/21/2023] Open
Abstract
Strategic @ERSTalk-@WHO alliance to address tobacco use by training health professionals on brief advice resulted in establishing smoking cessation in real care settings with quit rates higher than the literature and high propensity for wider dissemination http://ow.ly/lWDF30krq5V.
Collapse
Affiliation(s)
- Dongbo Fu
- Tobacco Free Initiative, Prevention of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland
| | - Christina Gratziou
- Smoking Cessation Centre, Evgenidio Hospital, Athens, Greece
- National and Kapodistrian University of Athens, Athens, Greece
| | | | - Marine Faure
- Advocacy and EU Affairs, European Respiratory Society, Brussels, Belgium
| | - Brian Ward
- Advocacy and EU Affairs, European Respiratory Society, Brussels, Belgium
| | - Sofia Ravara
- Faculty of Health Sciences, University of Beira Interior, Covilha, Portugal
- Public Health Research Centre (CISP), ENSP, NOVA University, Lisbon, Portugal
| | - Vinayak Mohan Prasad
- Tobacco Free Initiative, Prevention of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland
| | | | - Jagdish Kaur
- World Health Organization Regional Office for South-East Asia, New Delhi, India
| | - Angela Ciobanu
- WHO Country Office, Republic of Moldova, Chisinau, Moldova
| | | | - Paraskevi Katsaounou
- First ICU Evaggelismos Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
17
|
Chaouat A, Cherifi A, Sitbon O, Girerd N, Zysman M, Faure M, Mandry D, Mercy M, Guillaumot A, Fay R, Marie PY, Chabot F. [Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension]. Rev Mal Respir 2018; 35:749-758. [PMID: 29945811 DOI: 10.1016/j.rmr.2018.01.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2017] [Accepted: 01/12/2018] [Indexed: 01/25/2023]
Abstract
Haemodynamic follow up in pulmonary arterial hypertension (PAH) is currently based on right heart catheterisation (RHC). The primary objective of the EVITA study is to compare the use of cardiac magnetic resonance imaging (cMRI) with RHC in the identification of an unfavourable hemodynamic status. The secondary objectives are to determine the role of cMRI in the follow up process. Patients will undergo at diagnosis and at follow up visits both RHC and cMRI. Patients will be followed and treated according to the current guidelines. The primary endpoint will be an unfavourable haemodynamic status defined by cardiac index<2.5L/min/m2 or a right atrial pressure≥8mm Hg measured with RHC compared with a cardiac index<2.5L/min/m2 or right ventricle ejection fraction<35% or an absolute decrease of 10% from the previous measurement with cMRI. Exact values of sensitivity, specificity and 95% confidence intervals will be computed. A population of 180 subjects will have a power of 90% with an α risk of 5%. Univariate and multivariate Cox analysis will allow answering to the secondary objectives. We expect to demonstrate that cMRI could be partly used instead of RHC in the follow up of patients with PAH.
Collapse
Affiliation(s)
- A Chaouat
- Département de pneumologie, CHRU de Nancy, pôle des spécialités médicales, 54500 Vandoeuvre-lès-Nancy, France; INGRES, EA 7298, université de Lorraine, 54500 Vandoeuvre-lès-Nancy, France.
| | - A Cherifi
- CIC-IT, CHRU de Nancy, pôle des structures de soutien à la recherche, 54500 Vandœuvre-lès-Nancy, France
| | - O Sitbon
- Service de Pneumologie, hôpital Bicêtre, AP-HP, 94270 Le Kremlin-Bicêtre, France; Inserm UMR S 999, hôpital Marie-Lannelongue, 92350 Le Plessis-Robinson, France
| | - N Girerd
- CIC-P, CHRU de Nancy, pôle des structures de soutien à la recherche, 54500 Vandœuvre-lès-Nancy, France
| | - M Zysman
- Département de pneumologie, CHRU de Nancy, pôle des spécialités médicales, 54500 Vandoeuvre-lès-Nancy, France; Équipe 4, Inserm U955, institut Mondor de recherche biomédicale, 92000 Créteil, France
| | - M Faure
- Département de pneumologie, CHRU de Nancy, pôle des spécialités médicales, 54500 Vandoeuvre-lès-Nancy, France
| | - D Mandry
- Département de radiologie, CHRU de Nancy, pôle imagerie, 54500 Vandœuvre-lès-Nancy, France; U947, IADI, université de Lorraine, 54500 Vandœuvre-lès-Nancy, France
| | - M Mercy
- Département de pneumologie, CHRU de Nancy, pôle des spécialités médicales, 54500 Vandoeuvre-lès-Nancy, France
| | - A Guillaumot
- Département de pneumologie, CHRU de Nancy, pôle des spécialités médicales, 54500 Vandoeuvre-lès-Nancy, France
| | - R Fay
- CIC-P, CHRU de Nancy, pôle des structures de soutien à la recherche, 54500 Vandœuvre-lès-Nancy, France
| | - P-Y Marie
- Médecine nucléaire, CHRU de Nancy, pôle imagerie, 54500 Vandœuvre-lès-Nancy, France
| | - F Chabot
- Département de pneumologie, CHRU de Nancy, pôle des spécialités médicales, 54500 Vandoeuvre-lès-Nancy, France; INGRES, EA 7298, université de Lorraine, 54500 Vandoeuvre-lès-Nancy, France
| |
Collapse
|
18
|
Glahn A, Kyriakos CN, Loghin CR, Nguyen D, Starchenko P, Jimenez-Ruiz C, Faure M, Ward B. Tobacco control achievements and priority areas in the WHO Europe Region: A review. Tob Prev Cessat 2018; 4:15. [PMID: 32411843 PMCID: PMC7205061 DOI: 10.18332/tpc/89925] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 03/28/2018] [Accepted: 04/13/2018] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Tobacco control efforts have been advancing globally, including the adoption and entry into force of the World Health Organization (WHO) Framework Convention of Tobacco Control (FCTC), as well as the adoption of the European Union EU Tobacco Products Directive. With the present review, the European Network for Smoking and Tobacco Prevention (ENSP) and European Respiratory Society (ERS) aim to provide a comprehensive overview on the status of WHO FCTC implementation, policy achievements and priority areas across countries in the WHO Europe Region. METHODS The review was conducted through a triangulation of data extracted from a survey administered to ENSP members, the WHO FCTC Implementation Database, Tobacco Control Laws and the Tobacco Control Scale 2016. RESULTS Using the WHO MPOWER measures as a framework, we report on the implementation status of nine FCTC articles across 47 countries in the WHO Europe Region. The average number of articles fully implemented was 3.58. FCTC articles least fully implemented were: Article 5.3 on Tobacco Industry Interference (25.5%, n=12), Article 20 on Research (34.0%, n=16), and Article 15 on Illicit trade (40.4%, n=19). The most commonly fully implemented articles were: Article 8 on Smoke-free legislation (63.8%, n=30), Article 16 on Underage sales (57.4%, n=27), and Article 6 on Price and tax measures (51.2%, n=24). Policy achievements and recommended priority areas for future national tobacco control activities varied greatly among countries. CONCLUSIONS Findings highlight the multitude of successes in tobacco control efforts across the region in recent years, but point out the need to address gaps in FCTC implementation.
Collapse
Affiliation(s)
- Andrea Glahn
- European Network for Smoking and Tobacco Prevention, Brussels Belgium
| | | | | | - Dominick Nguyen
- European Network for Smoking and Tobacco Prevention, Brussels Belgium
| | - Polina Starchenko
- European Network for Smoking and Tobacco Prevention, Brussels Belgium
| | - Carlos Jimenez-Ruiz
- Smoking Cessation Service of Region Madrid, Spain
- European Respiratory Society, Lausanne, Switzerland
| | - Marine Faure
- European Respiratory Society, Lausanne, Switzerland
| | - Brian Ward
- European Respiratory Society, Lausanne, Switzerland
| |
Collapse
|
19
|
Koszutski M, Faure M, Guillaumot A, Gomez E, Mercy M, Chabot F, Chaouat A. [Tunnelled central venous catheter infection during treatment with epoprostenol]. Rev Mal Respir 2018; 35:324-327. [PMID: 29602480 DOI: 10.1016/j.rmr.2017.03.037] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2016] [Accepted: 03/31/2017] [Indexed: 11/26/2022]
Abstract
INTRODUCTION Pulmonary arterial hypertension is a pulmonary vascular disease with a poor prognosis. Continuous intravenous treatment with prostacyclin analogues requires the placement of a tunnelled catheter. The occurrence of catheter-related infections in this context is unusual due to the alkaline pH of the prostacyclin analogue solutions. OBSERVATION A 50-year-old patient with inherited pulmonary artery hypertension, treated with bosentan, sildenafil and epoprostenol, experienced generalized malaise associated with a weight loss of 9kg over a 12-month period without evidence of a source of infection or malignancy. There was no evidence of hemodynamic disturbance. The diagnosis was made after 1 year of follow-up, when the patient presented with a 38° fever and a biological inflammatory syndrome. Repeated peripheral blood cultures were positive for Dietzia, an alkalophilic coryneform bacillus. The patient's condition responded favourably to antibiotic therapy. CONCLUSION Infection of a tunneled intravenous catheter should be considered in the case of non-specific symptoms or where there is evidence of sepsis, in patients treated with intravenous prostacyclin analogues administered intravenously. In this context, the laboratory should be warned to search for slow-growing organisms.
Collapse
Affiliation(s)
- M Koszutski
- Pôle des spécialités médicales, département de pneumologie, CHU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France.
| | - M Faure
- Pôle des spécialités médicales, département de pneumologie, CHU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - A Guillaumot
- Pôle des spécialités médicales, département de pneumologie, CHU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - E Gomez
- Pôle des spécialités médicales, département de pneumologie, CHU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - M Mercy
- Pôle des spécialités médicales, département de pneumologie, CHU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - F Chabot
- Pôle des spécialités médicales, département de pneumologie, CHU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - A Chaouat
- Pôle des spécialités médicales, département de pneumologie, CHU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France; INGRES, EA 7298, université de lorraine, 54500 Vandœuvre-lès-Nancy, France
| |
Collapse
|
20
|
Vardavas C, Filippidis FT, Ward B, Faure M, Jimenez-Ruiz C, Gratziou C, Katsaounou P, Lozano F, Behrakis P, Radu-Loghin C. Plain packaging of tobacco products in the European Union: an EU success story? Eur Respir J 2017; 50:50/5/1701232. [DOI: 10.1183/13993003.01232-2017] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2017] [Accepted: 10/02/2017] [Indexed: 11/05/2022]
|
21
|
Faure M, Hollebecque A, Bahleda R, Soria JC, Dyevre V. FGFR pathway genomic aberrations and response to FGFRs inhibitors. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx390.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
22
|
Rousseau C, Peyrière H, Tribout V, Brosson I, de Carvalho E, Verdier J, Derrien J, Jacquet J, Faure M, Ferreyra M, Lugaz V, Aumaitre H, Reynes J. Profil des consommateurs de substances psychoactives chez les consultants des CDAG-CIDDIST du Languedoc–Roussillon en 2014 : évaluation du risque sexuel lié à l’usage de substances. Therapie 2017. [DOI: 10.1016/j.therap.2016.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
23
|
Koszutski M, Faure M, Guillaumot A, Mercy M, Gomez E, Chabot F, Chaouat A. Comparaison des mesures hémodynamiques pulmonaires à l’effort entre l’hypertension pulmonaire sévère du groupe 3 et l’hypertension artérielle pulmonaire. Rev Mal Respir 2017. [DOI: 10.1016/j.rmr.2016.10.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
24
|
Corré J, Poustis P, Bonnet G, Robino P, Anthierens C, Faure M, Douard H. Rationalization of complementary tests in cardiology department. Archives of Cardiovascular Diseases Supplements 2017. [DOI: 10.1016/s1878-6480(17)30233-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
25
|
Jacquemus J, Dalle S, Faure M, Chouvet B, Beatrix O, Balme B. [Malignant transformation of an eccrine spiradenoma]. Ann Dermatol Venereol 2016; 144:203-207. [PMID: 28277254 DOI: 10.1016/j.annder.2016.09.038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2016] [Revised: 04/20/2016] [Accepted: 09/02/2016] [Indexed: 01/05/2023]
Abstract
INTRODUCTION Malignant eccrine spiradenoma is a rare and aggressive tumor, developed on the epithelium of eccrine sweat glands. Typically, it occurs after malignant transformation of benign eccrine spiradenoma, but sometimes it happens de novo. OBSERVATION We report a case of malignant eccrine spiradenoma in a 62-year-old woman. The patient presented a rapid increase in size of a long-standing tumoral lesion of her forearm. There was no secondary lesion on the chest, abdomen or pelvis at the CT-scanner. Cutaneous biopsy of the lesion was performed and showed a carcinoma with no contact with epidermis. On this biopsy, we could not affirm if the tumor was a metastatic process or a primary tumor of the skin. Histologic examination of the surgical removal of the tumor showed an undifferentiated carcinoma with adjacent nodules of eccrine spiradenoma. Immunohistochemical assessment of Ki67 expression showed a weak expression (5%) in the benign spiradenoma nodules and a high rate expression (80%) in the malignant neoplasm. The final diagnosis was an undifferentiated carcinoma arising from preexisting benign spiradenoma. DISCUSSION Malignant eccrine spiradenoma is not frequent and is rarely described in the international literature that may lead to diagnostic difficulties.
Collapse
Affiliation(s)
- J Jacquemus
- Service de pathologie, centre hospitalier Lyon sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France.
| | - S Dalle
- Service de dermatologie, centre hospitalier Lyon sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France
| | - M Faure
- Service de dermatologie, hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France
| | - B Chouvet
- Service de pathologie, hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France
| | - O Beatrix
- Service de chirurgie, centre hospitalier Lyon sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France
| | - B Balme
- Service de pathologie, centre hospitalier Lyon sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France
| |
Collapse
|
26
|
Faure M, Alves S, Rouillon C, Jeanpierre E, Ramé C, Dupont J, Froment P. Consequence of anti-diabetic treatment in utero on male mouse fertility. Annales d'Endocrinologie 2016. [DOI: 10.1016/j.ando.2016.07.206] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
27
|
Faure M, Guibert E, Alves S, Pain B, Ramé C, Dupont J, Brillard JP, Froment P. The insulin sensitiser metformin regulates chicken Sertoli and germ cell populations. Reproduction 2016; 151:527-38. [DOI: 10.1530/rep-15-0565] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2015] [Accepted: 02/25/2016] [Indexed: 11/08/2022]
Abstract
Abstract
Metformin, an insulin sensitiser from the biguanide family of molecules, is used for the treatment of insulin resistance in type 2 diabetes individuals. It increases peripheral glucose uptake and may reduce food intake. Based on the tight link between metabolism and fertility, we investigated the role of metformin on testicular function using in vitro culture of Sertoli cells and seminiferous tubules, complemented by in vivo data obtained following metformin administration to prepubertal chickens. In vitro, metformin treatment reduced Sertoli cell proliferation without inducing apoptosis and morphological changes. The metabolism of Sertoli cells was affected because lactate secretion by Sertoli cells increased approximately twofold and intracellular free ATP was negatively impacted. Two important pathways regulating proliferation and metabolism in Sertoli cells were assayed. Metformin exposure was not associated with an increased phosphorylation of AKT or ERK. There was a 90% reduction in the proportion of proliferating germ cells after a 96-h exposure of seminiferous tubule cultures to metformin. In vivo, 6-week-old chickens treated with metformin for 3 weeks exhibited reduced testicular weight and a 50% decrease in testosterone levels. The expression of a marker of undifferentiated germ cells was unchanged in contrast to the decrease in expression of ‘protamine’, a marker of differentiated germ cells. In conclusion, these results suggest that metformin affects the testicular energy content and the proliferative ability of Sertoli and germ cells.
Reproduction (2016) 151 527–538
Collapse
|
28
|
Affiliation(s)
- Marine Faure
- European Respiratory Society, EU Affairs Dept, Brussels, Belgium
| |
Collapse
|
29
|
Faure M, Gomez E, Dorfmuller P, Mandry D, Canuet M, Kessler R, Chabot F, Chaouat A. Hypertension pulmonaire sévère associée à un emphysème sans déficit ventilatoire obstructif, révélant une maladie veino-occlusive pulmonaire. Rev Mal Respir 2016. [DOI: 10.1016/j.rmr.2015.10.428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
De Battista M, Faure M. Living lab: A interdisciplinarity and multifunctional tool for elderly people's quality of life at home. Ann Phys Rehabil Med 2015. [DOI: 10.1016/j.rehab.2015.07.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
|
32
|
Faure M. A free lung health check for the European Parliament: Healthy Lungs for Life. Eur Respir J 2015; 45:1224-5. [DOI: 10.1183/09031936.00022615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
33
|
Faivre C, Aubin F, Bottaro M, Cohen JD, Durupt F, Lipsker D, Debarbieux S, Jeudy G, Morel J, Toussirot E, Faure M, Jullien D. Apparition d’une maladie de Verneuil sous biothérapie : une série de 14 cas. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
34
|
Masasa T, Irwin-Carruthers S, Faure M. Knowledge of, beliefs about and attitudes to disability: implications for health professionals. S Afr Fam Pract (2004) 2014. [DOI: 10.1080/20786204.2005.10873260] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
35
|
Mohsin N, Mourad G, Faure M, Szawarc I, Bringer J. Metabolic Syndrome Performs Better Than the Individual Factors in Predicting Renal Graft Outcome. Transplant Proc 2013; 45:3517-9. [DOI: 10.1016/j.transproceed.2013.09.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
36
|
Ducroux E, Ocampo MA, Kanitakis J, Morelon E, Jullien D, Faure M, Euvrard S. Maladie de Verneuil après transplantation rénale : rémission complète après remplacement de la ciclosporine par le tacrolimus. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
37
|
Mohsin N, Faure M, Szwarc I, Pernin V, Mourad G. Different Classifications Yield Variance in Metabolic Syndrome Prevalence and Dynamics in Renal Transplant Recipients. Transplant Proc 2013; 45:3514-6. [DOI: 10.1016/j.transproceed.2013.08.094] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Vola M, Fuzellier JF, Campisi S, Bouchet JB, Faure M. 321-I * VIDEO-ASSISTED MINITHORACOTOMY SUTURELESS AORTIC VALVE REPLACEMENT WITH THE ENABLE I(R) DEVICE. Interact Cardiovasc Thorac Surg 2013. [DOI: 10.1093/icvts/ivt372.321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Barret AS, Charron M, Mariani-Kurkdjian P, Gouali M, Loukiadis E, Poignet-Leroux B, Godron A, Gault G, Faure M, Mailles A. Shopper cards data and storage practices for the investigation of an outbreak of Shiga-toxin producing Escherichia coli O157 infections. Med Mal Infect 2013; 43:368-73. [PMID: 23910937 DOI: 10.1016/j.medmal.2013.05.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2013] [Revised: 03/18/2013] [Accepted: 05/24/2013] [Indexed: 11/30/2022]
Abstract
INTRODUCTION An outbreak of shiga-toxin producing Escherichia coli infections occurred in southwest France in June 2012. The outbreak was investigated to identify the source of infection, and guide control measures. METHODS Confirmed outbreak cases were patients who developed bloody diarrhoea or haemolytic uremic syndrome (HUS) between 28 May and 6 July 2012, with E. coli O157 isolates showing indistinguishable patterns on pulse field gel electrophoresis (PFGE). A standardized questionnaire was administered to patients to document food consumption and other risk exposures. Their purchase was checked through their supermarket shopper card data. RESULTS Six patients (four with HUS and two with bloody diarrhea) were confirmed outbreak cases. Fresh ground beef burgers from one supermarket were the only common food exposure, identified by interviews and shopper card data. The PFGE profile of shiga toxin-producing E. coli O157 isolated from the suspected beef burgers was identical to those from the human cases. The suspected beef burgers were no longer on sale at the time of investigation but three patients confirmed as outbreak cases had deep-frozen some at home. CONCLUSION Shopper card data was particularly useful to obtain precise and reliable information on the traceability of consumed food. Despite the expired use-by date, a recall was issued for the beef burgers. This contributed to preventing other cases among consumers who had deep-frozen the beef burgers.
Collapse
Affiliation(s)
- A-S Barret
- Institut de veille sanitaire, département des maladies infectieuses, 12, rue du Val-d'Osne, 94415 Saint-Maurice cedex, France.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Gérardin F, Cloteaux A, Guillemot M, Faure M, André JC. Photocatalytic conversion of gaseous nitrogen trichloride into available chlorine--experimental and modeling study. Environ Sci Technol 2013; 47:4628-4635. [PMID: 23566077 DOI: 10.1021/es400588m] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
In water, chlorine reacts with nitrogen-containing compounds to produce disinfection byproducts such as nitrogen trichloride which induces ocular and respiratory irritations in swimming pool workers. A technical solution has been used to reduce NCl3 exposure to acceptable levels, by adding a stripping step to the water recycling loop. The pollutants extracted are currently rejected into the atmosphere without treatment. However, the physical properties of NCl3 could be harnessed to induce its controlled degradation by direct or indirect light. This paper describes the way to transform NCl3 into oxidizing chlorine by photocatalysis under laboratory conditions. Photocatalytic oxidation efficiently degrades gaseous nitrogen trichloride, producing compounds such as HClO. About 60% of NCl3 decomposed was converted into HClO which could be used as a disinfection compound. A kinetic model is proposed for the photocatalytic process based on a convection/diffusion model. The Langmuir-Hinshelwood model was applied to the chemical part of the mechanism. The apparent quantum yield was also estimated to assess the optimal irradiance for NCl3 transformation. The results show that photocatalysis performs much better than photolysis alone for NCl3 removal, i.e. at least 25 times more efficient.
Collapse
Affiliation(s)
- F Gérardin
- Institut National de Recherche et de Sécurité, Rue du Morvan, CS60027, 54519 Vandœuvre Cedex, France.
| | | | | | | | | |
Collapse
|
41
|
Juruj C, Lelogeais V, Pierini R, Perret M, Py BF, Jamilloux Y, Broz P, Ader F, Faure M, Henry T. Caspase-1 activity affects AIM2 speck formation/stability through a negative feedback loop. Front Cell Infect Microbiol 2013; 3:14. [PMID: 23630667 PMCID: PMC3633939 DOI: 10.3389/fcimb.2013.00014] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2013] [Accepted: 04/05/2013] [Indexed: 11/13/2022] Open
Abstract
The inflammasome is an innate immune signaling platform leading to caspase-1 activation, maturation of pro-inflammatory cytokines and cell death. Recognition of DNA within the host cytosol induces the formation of a large complex composed of the AIM2 receptor, the ASC adaptor and the caspase-1 effector. Francisella tularensis, the agent of tularemia, replicates within the host cytosol. The macrophage cytosolic surveillance system detects Francisella through the AIM2 inflammasome. Upon Francisella novicida infection, we observed a faster kinetics of AIM2 speck formation in ASCKO and Casp1KO as compared to WT macrophages. This observation was validated by a biochemical approach thus demonstrating for the first time the existence of a negative feedback loop controlled by ASC/caspase-1 that regulates AIM2 complex formation/stability. This regulatory mechanism acted before pyroptosis and required caspase-1 catalytic activity. Our data suggest that sublytic caspase-1 activity could delay the formation of stable AIM2 speck, an inflammasome complex associated with cell death.
Collapse
Affiliation(s)
- C Juruj
- International Center for Infectiology Research, Université de Lyon Lyon, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Ocampo MA, Decullier E, Arbona Vidal E, Kanitakis J, Philit F, Mornex JF, Faure M, Euvrard S. Cancers cutanés après greffe pulmonaire. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
43
|
Mailles A, Rautureau S, Le Horgne JM, Poignet-Leroux B, d’Arnoux C, Dennetière G, Faure M, Lavigne JP, Bru JP, Garin-Bastuji B. Re-emergence of brucellosis in cattle in France and risk for human health. Euro Surveill 2012. [DOI: 10.2807/ese.17.30.20227-en] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
A case of human brucellosis was diagnosed in France in January 2012. The investigation demonstrated that the case had been contaminated by raw milk cheese from a neighbouring dairy farm. As France has been officially free of bovine brucellosis since 2005, veterinary investigations are being conducted to determine the origin of the infection and avoid its spread among other herds. Hypotheses about the source of this infection are discussed.
Collapse
Affiliation(s)
- A Mailles
- French Institute for Public Health Surveillance (Institut de Veille Sanitaire; InVS), Saint Maurice, France
| | - S Rautureau
- French Ministry of Agriculture, Agro-food Industry and Forest, General Directorate for Food, Paris, France
| | - J M Le Horgne
- District veterinary services of Haute Savoie, Annecy, France
| | - B Poignet-Leroux
- French Ministry of Agriculture, Agro-food Industry and Forest, General Directorate for Food, Paris, France
| | - C d’Arnoux
- Health regional Agency (Agences Régionales de Santé; ARS) Rhône Alpes, Lyon, France
| | - G Dennetière
- Regional office of the French Institute for Public Health Surveillance, Lyon, France
| | - M Faure
- French Ministry of Health, General directorate for health, Paris, France
| | - J P Lavigne
- Associate national reference laboratory, Microbiology department, University hospital Caremeau, Nimes, France
| | - J P Bru
- Infectious diseases department, General hospital, Annecy, France
| | - B Garin-Bastuji
- French Agency for Food, Environmental and Occupational Health Safety (Agence Nationale de Sécurité Sanitaire de l'Alimentation; Anses), National Reference Laboratory for Human and Animal Brucellosis, Maisons-Alfort, France
| |
Collapse
|
44
|
Mailles A, Rautureau S, Le Horgne JM, Poignet-Leroux B, d'Arnoux C, Dennetière G, Faure M, Lavigne JP, Bru JP, Garin-Bastuji B. Re-emergence of brucellosis in cattle in France and risk for human health. Euro Surveill 2012; 17:20227. [PMID: 22856510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
Abstract
A case of human brucellosis was diagnosed in France in January 2012. The investigation demonstrated that the case had been contaminated by raw milk cheese from a neighbouring dairy farm. As France has been officially free of bovine brucellosis since 2005, veterinary investigations are being conducted to determine the origin of the infection and avoid its spread among other herds. Hypotheses about the source of this infection are discussed.
Collapse
Affiliation(s)
- A Mailles
- French Institute for Public Health Surveillance-Institut de Veille Sanitaire-InVS, Saint Maurice, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Mohsin N, Szwarz I, Pernin V, Faure M, Mourad G. Influence du syndrome métabolique sur la survie et la fonction du greffon rénal. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Mohsin N, Szwarz I, Pernin V, Faure M, Mourad G. La prévalence du syndrome métabolique chez les transplantés rénaux varie selon la classification. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
47
|
Kanitakis J, Arbona-Vidal E, Faure M. Porokeratosis in patients with polycythemia rubra vera: a new side effect of hydroxyurea? J Eur Acad Dermatol Venereol 2011; 26:1040-1. [DOI: 10.1111/j.1468-3083.2011.04202.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
48
|
Trimoulet P, Belzunce C, Faure M, Wittkop L, Reigadas S, Dupon M, Ragnaud JM, Fleury H, Neau D. Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients. HIV Med 2011; 12:506-9. [DOI: 10.1111/j.1468-1293.2011.00913.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
49
|
Karachi F, Hanekom S, Faure M. Health-related quality of life of patients 12 months following surgical intensive care discharge. South African Journal of Physiotherapy 2011. [DOI: 10.4102/sajp.v67i1.36] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
Health related quality of life (HRQoL) and the effect of selected socio-demographic and clinical intensive care variables on HRQoL of patients 12 months following adult surgical intensive care unit discharge in the Western Cape was evaluated. A prospective observational study was conducted. The sample comprised 46 patients who had survived 12 months following discharge. Structured telephonic interviews were conducted using a self-developed and SF-36v2 HRQoL questionnaire. Data was analyzed using Stastica 7 and values were accepted as significant at the 5% level. Low mean HRQoL domain scores (43% - 53%) were found implying a poor HRQoL outcome. Physical functioning [43.5%], Role Play [44.5%] and Role Emotion [43.1%] scores were specifically lower than the other HRQoL domain scores. Age and severity of illness scores (APACHE II) were significantly associated with the social functioning (p=0.01) and physical functioning (p=0.02) scores respectively. APACHE II may be a useful contributor in predicting long-term physical functioning outcomes in patients following surgical ICU discharge. The HRQoL outcomes are slightly lower than that found for inter-national ICU populations however responses in the domains affected are comparable. Low physical functioning, role play and role emotion scores indicate a need for further physical and emotional rehabilitation following surgical ICU discharge.
Collapse
|
50
|
Kanitakis J, Lora V, Chouvet B, Zambruno G, Haftek M, Faure M. Circumscribed palmo-plantar hypokeratosis: a disease of desquamation? Immunohistological study of five cases and literature review. J Eur Acad Dermatol Venereol 2011; 25:296-301. [PMID: 20626532 DOI: 10.1111/j.1468-3083.2010.03784.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- J Kanitakis
- Department of Dermatology (Pav. R) and Laboratory of Dermatopathology (Bldg 10), Ed. Herriot Hospital, Lyon cx 03, France.
| | | | | | | | | | | |
Collapse
|